2 completed, 1 terminated, 1 unknown. 4 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 2, Terminated 1, Unknown 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Dynogen Pharmaceuticals: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females DDP733 - Irritable Bowel Syndrome | Phase 2 / Phase 3 | Unknown | Dynogen Pharmaceuticals | 360 | 2007-10-01 | 2008-04-08 |
| 12 Weeks Treatment With DDP225 or Placebo in Patients With Chronic Functional Vomiting DDP225 - Vomiting | Phase 2 | Terminated | Dynogen Pharmaceuticals | 30 | 2005-11-01 | 2007-10-12 |
| 8 Weeks Treatment With DDP225 in Patients With Diarrhea Predominant IBS DDP225 - Irritable Bowel Syndrome | Phase 2 | Completed | Dynogen Pharmaceuticals | 88 | 2005-09-01 | 2007-10-15 |
| A Study to Evaluate the Safety, Tolerability and Pharmacodynamics of DDP733 for IBS-c DDP733 - Irritable Bowel Syndrome With Constipation, Irritable Bowel Syndrome | Phase 2 | Completed | Dynogen Pharmaceuticals | 90 | 2005-09-01 | 2007-05-28 |
Irritable Bowel Syndrome (3) · Ichthyosis Bullosa of Siemens (1) · Nausea (1) · Vomiting (1)
DDP733 (2)
Canada (3) · United States (3)
Ray Clouse, MD (1) · William Paterson, MD (1) · William Patterson, MD (1)